Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $4.72 -0.48 (-9.23%) As of 02/21/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrends HSAQ vs. RCEL, CATX, DRTS, NVRO, KRMD, OBIO, UTMD, BWAY, SKIN, and PROFShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include AVITA Medical (RCEL), Perspective Therapeutics (CATX), Alpha Tau Medical (DRTS), Nevro (NVRO), KORU Medical Systems (KRMD), Orchestra BioMed (OBIO), Utah Medical Products (UTMD), BrainsWay (BWAY), Beauty Health (SKIN), and Profound Medical (PROF). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. AVITA Medical Perspective Therapeutics Alpha Tau Medical Nevro KORU Medical Systems Orchestra BioMed Utah Medical Products BrainsWay Beauty Health Profound Medical Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) and AVITA Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability. Do analysts recommend HSAQ or RCEL? AVITA Medical has a consensus target price of $17.25, indicating a potential upside of 76.92%. Given AVITA Medical's stronger consensus rating and higher probable upside, analysts clearly believe AVITA Medical is more favorable than Health Sciences Acquisitions Co. 2.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Sciences Acquisitions Co. 2 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00AVITA Medical 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Does the media refer more to HSAQ or RCEL? In the previous week, AVITA Medical had 12 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 12 mentions for AVITA Medical and 0 mentions for Health Sciences Acquisitions Co. 2. AVITA Medical's average media sentiment score of 0.66 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that AVITA Medical is being referred to more favorably in the news media. Company Overall Sentiment Health Sciences Acquisitions Co. 2 Neutral AVITA Medical Positive Which has preferable valuation and earnings, HSAQ or RCEL? Health Sciences Acquisitions Co. 2 has higher earnings, but lower revenue than AVITA Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/AAVITA Medical$64.25M3.98-$61.85M-$2.39-4.08 Is HSAQ or RCEL more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to AVITA Medical's net margin of -96.26%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat AVITA Medical's return on equity.Company Net Margins Return on Equity Return on Assets Health Sciences Acquisitions Co. 2N/A N/A -2.38% AVITA Medical -96.26%-337.91%-71.50% Do insiders & institutionals believe in HSAQ or RCEL? 89.7% of Health Sciences Acquisitions Co. 2 shares are held by institutional investors. Comparatively, 27.7% of AVITA Medical shares are held by institutional investors. 21.9% of Health Sciences Acquisitions Co. 2 shares are held by company insiders. Comparatively, 1.8% of AVITA Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, HSAQ or RCEL? Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, AVITA Medical has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Does the MarketBeat Community favor HSAQ or RCEL? AVITA Medical received 80 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users. CompanyUnderperformOutperformHealth Sciences Acquisitions Co. 2N/AN/AAVITA MedicalOutperform Votes8069.57% Underperform Votes3530.43% SummaryAVITA Medical beats Health Sciences Acquisitions Co. 2 on 8 of the 14 factors compared between the two stocks. Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.92M$4.74B$5.84B$9.15BDividend YieldN/A39.90%4.75%3.85%P/E RatioN/A29.3426.3819.16Price / SalesN/A53.64435.3370.72Price / CashN/A51.1038.0134.83Price / Book-7.616.577.644.62Net Income-$380,000.00$90.91M$3.19B$246.06M7 Day Performance-16.75%-2.39%-2.12%-2.63%1 Month Performance-8.70%-2.29%-0.44%-2.15%1 Year Performance-17.05%15.21%16.30%12.88% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$4.72-9.2%N/A-11.9%$52.92MN/A0.004RCELAVITA Medical1.5673 of 5 stars$8.80+1.4%$18.00+104.5%-44.0%$230.74M$50.14M-3.95130Upcoming EarningsAnalyst ForecastInsider TradeNews CoverageGap UpCATXPerspective Therapeutics1.6313 of 5 stars$3.24-2.1%$15.14+367.4%N/A$218.99M$1.43M0.0070Gap UpDRTSAlpha Tau Medical2.9174 of 5 stars$3.11-0.3%$8.00+157.2%-12.1%$217.45MN/A-7.2380Positive NewsGap UpNVRONevro1.8713 of 5 stars$5.72-0.1%$6.43+12.4%-65.3%$214.19M$419.15M-3.021,215Analyst ForecastKRMDKORU Medical Systems3.3402 of 5 stars$4.65+0.6%$4.50-3.2%+79.2%$213.16M$28.52M-18.6080OBIOOrchestra BioMed2.7336 of 5 stars$5.58+1.6%$16.25+191.2%-18.3%$212.10M$2.76M-3.474UTMDUtah Medical Products3.6126 of 5 stars$60.43+1.0%N/A-15.9%$204.86M$40.90M15.30180Positive NewsBWAYBrainsWay2.488 of 5 stars$10.74+4.7%$13.17+22.6%+70.1%$202.13M$31.78M107.41120Gap UpHigh Trading VolumeSKINBeauty Health1.6557 of 5 stars$1.62+4.5%$2.55+57.4%-42.5%$201.07M$398M-3.861,030News CoveragePositive NewsPROFProfound Medical3.1741 of 5 stars$5.85-2.5%$14.25+143.6%-9.3%$175.73M$7.20M-4.37150Analyst RevisionNews Coverage Related Companies and Tools Related Companies AVITA Medical Competitors Perspective Therapeutics Competitors Alpha Tau Medical Competitors Nevro Competitors KORU Medical Systems Competitors Orchestra BioMed Competitors Utah Medical Products Competitors BrainsWay Competitors Beauty Health Competitors Profound Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSAQ) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSAQ Stock Alerts